|1|MRP2 (ABCC2, cMOAT) expression in nuclear envelope of primary fallopian tube cancer cells is a new unfavorable prognostic factor. (23135210)
Halon A.... Surowiak P.
|2|Early detection of ovarian and fallopian tube cancer by examination of cytological samples from the endometrial cavity. (23868002)
Otsuka I.... Hoshi K.
|3|Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in brca;tp53;pten models. (24332043)
Perets R.... Drapkin R.
|4|OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer. (22529265)
Aghajanian C.... Nycum L.R.
|5|Outcome of single agent generic gemcitabine in platinum-resistant ovarian cancer, fallopian tube cancer and primary peritoneal adenocarcinoma. (22524817)
Suprasert P.... Manopunya M.
|6|Multidrug resistance gene (MDR-1) and risk of brain metastasis in epithelial ovarian, fallopian tube, and peritoneal cancer. (20921883)
Matsuo K.... Sood A.K.
|7|Junctional epithelial zones of the fallopian tube: cancer hotspots? (21131841)
Rabban J.T.... Zaloudek C.J.
|8|Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: results of a phase 2 study. (21815133)
McGonigle K.F.... Malpass T.W.
|9|Phase I study of pemetrexed and pegylated liposomal doxorubicin in patients with refractory breast, ovarian, primary peritoneal, or fallopian tube cancer. (20352294)
Richards D.A.... Tai D.F.
|10|Expression of Semaphorin 3F and Its Receptors in Epithelial Ovarian Cancer, Fallopian Tubes, and Secondary MA1llerian Tissues. (20041133)
Drenberg C.D.... Nicosia S.V.
|11|A phase II study of GM-CSF and rIFN-gamma1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer. (19264351)
Schmeler K.M.... Freedman R.S.
|12|Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer. (19826113)
Matulonis U.A.... Penson R.T.
|13|Phase II evaluation of nanoparticle albumin-bound paclitaxel in platinum-sensitive patients with recurrent ovarian, peritoneal, or fallopian tube cancer. (19224848)
Teneriello M.G.... Asmar L.
|14|High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy. (19574767)
Hirst J.E.... Field M.
|15|Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer. (19091388)
Kehoe S.M.... Chi D.S.
|16|Systematic lymphadenectomy improves survival in patients with advanced-stage primary fallopian tube cancer. (19398867)
Kim Y.M.... Nam J.H.
|17|Validation of epithelial ovarian cancer and fallopian tube cancer and ovarian borderline tumor data in the Danish Gynecological Cancer Database. (19308749)
Petri A.L.... Hogdall C.
|18|A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer. (18554700)
Konner J.... Aghajanian C.A.
|19|Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia. (18423560)
Nimeiri H.S.... .
|20|A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. (18342932)
Folkins A.K.... Crum C.P.
|21|Fallopian tube cancer associated with paraneoplastic dermatomyositis -- asymptomatic multivisceral exacerbated dermatomyositis mimicking recurrent widespread malignant disease: case report. (18459555)
Seeber J.... Zeimet A.G.
|22|Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: a phase I and feasibility trial of the Gynecologic Oncology Group. (18597837)
Morgan M.A.... Egorin M.J.
|23|Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer. (19006196)
Wethington S.L.... Wright J.D.
|24|Treatment of recurrent or persistent platinum-refractory ovarian, fallopian tube or primary peritoneal cancer with gemcitabine and topotecan: a phase II trial of the Puget Sound Oncology Consortium. (18538834)
Goff B.A.... Kurland B.F.
|25|Reversible posterior leukoencephalopathy syndrome following intravenous paclitaxel and intraperitoneal cisplatin chemotherapy for fallopian tube cancer. (18554701)
Onujiogu N.... Yamada S.D.
|26|Primary fallopian tube cancer may mimic endometrial malignancy. (18603511)
Lin C.K.... Yu M.H.
|27|Second primary malignancies in females with primary fallopian tube cancer. (17266029)
Riska A.... Brennan P.
|28|A phase II study of outpatient first-line paclitaxel, carboplatin, and bevacizumab for advanced-stage epithelial ovarian, peritoneal, and fallopian tube cancer. (17343605)
Micha J.P.... Brown J.V.
|29|The incidence of primary fallopian tube cancer in the United States. (17961642)
Stewart S.L.... Michaud F.
|30|Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. (17761984)
Callahan M.J.... Muto M.G.
|31|First report of primary fallopian tube cancer diagnosed by liquid-based cytology in an asymptomatic woman. (17877777)
Benjamin R.... Kirwan J.
|32|A 10-year review of primary fallopian tube cancer at a community hospital: a high association of synchronous and metachronous cancers. (16445606)
Benoit M.F.... Hannigan E.V.
|33|Inguinal node metastasis as the initial presentation of primary fallopian tube cancer. (16876236)
Cho J.... DA-az-Montes T.P.
|34|The significance of Doppler flow and anamnesis in the diagnosis of fallopian tube cancer. (15991534)
Gojnic M.... Jeremic K.
|35|A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer. (15581974)
Berkenblit A.... Cannistra S.A.
|36|BRCA2 germline mutations in primary cancer of the fallopian tube. (15254695)
Casarsa S.... Damante G.
|37|Occult cancer of the fallopian tube in a BRCA2 germline mutation carrier at prophylactic salpingo-oophorectomy. (14984974)
McEwen A.R.... Kidd A.M.
|38|Phase 2 trial of interferon-beta as second-line treatment of ovarian cancer, fallopian tube cancer, or primary carcinoma of the peritoneum. (15331919)
Markman M.... Lindner D.
|39|Phase 2 trial of single agent docetaxel in platinum and paclitaxel-refractory ovarian cancer, fallopian tube cancer, and primary carcinoma of the peritoneum. (14675679)
Markman M.... Belinson J.
|40|A novel Q3034R BRCA2 germline mutation identified in a fallopian tube cancer patient. (12618335)
Baudi F.... Venuta S.
|41|Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. (11745677)
Piek J.M.... Verheijen R.H.
|42|Long-term survival of a patient with fallopian tube cancer presenting with a supraclavicular mass. (11205221)
Scholz H.S.... Petru E.
|43|Fallopian tube cancer as a feature of BRCA1-associated syndromes. (10926816)
Sobol H.... Eisinger F.
|44|Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations. (10620440)
Zweemer R.P.... Kenemans P.
|45|Treatment of fallopian tube cancer. Review of the literature. (10985612)
Takeshima N.... Hasumi K.
|46|Prognostic significance of tumor angiogenesis in primary fallopian tube cancer. (10454260)
Bancher-Todesca D.... Obermair A.
|47|Fallopian tube cancer: incidence and role of lymphatic spread. (8751549)
di Re E.... Baiocchi G.
|48|Modulation of platinum sensitivity and resistance by cyclosporin A in refractory ovarian and fallopian tube cancer patients: a phase II study. (9816118)
Chambers S.K.... Chambers J.T.
|49|Fallopian tube cancer metastatic to the breast. (8005136)
Fishman A.... Kaplan A.L.
|50|Fallopian tube cancer: the role of radiation therapy. (3444903)
Schray M.F.... Malkasian G.D.